Factors Related to Conversion from Accelerated to Full Approval for Drugs Approved in the United States Between 2000 and 2016
Crossref DOI link: https://doi.org/10.1007/s43441-020-00192-6
Published Online: 2020-06-29
Published Print: 2021-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Irisawa, Koji https://orcid.org/0000-0002-4739-6191
Kaneko, Masayuki
Narukawa, Mamoru
Text and Data Mining valid from 2020-06-29
Version of Record valid from 2020-06-29
Article History
Received: 24 March 2020
Accepted: 18 June 2020
First Online: 29 June 2020
Compliance with Ethical Standards
:
: The authors have no conflicts of interest that are directly relevant to this research.